← Study Library
RCT · 2012 · n=10
Preclinicalcounts toward this tierComparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women
Sato T, Schurgers LJ, Uenishi K · Nutrition Journal
Preclinicalcounts toward this tier
MK-4 was undetectable in serum at every time point at nutritional doses, while MK-7 was well absorbed (serum peak ~6 h) and accumulated with daily dosing — the key pharmacokinetic argument for MK-7 over MK-4 at supplement-label doses.
- Population
- Ten healthy Japanese women aged 20-21, randomised to two groups of five in each of two studies: a single 420 microgram dose, or 60 micrograms a day for 7 days
- Intervention
- Menaquinone-4 (MK-4) vs menaquinone-7 (MK-7), single-dose and 7-day dosing
- Comparator
- MK-4 vs MK-7 head-to-head
- Limitations
- Five per group; the first author is employed by J-Oil Mills, which prepared the capsules (competing-interests statement; no funding source is stated); measures serum levels, not joint outcomes; high-dose MK-4 (45 mg/day) regimens not tested.
Cited by
1 entry references this study
- Vitamin K2 (MK-7)PROM.
Supplements → Vitamins & cofactors
Evidence for that entry
Promising